Sintilimab for Gastric Cancer, Lepodisiran Targeting Lipoprotein(a), CONSORT Extension for Factorial Trials, and more
Editor’s Summary by Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for the December 5, 2023, issue. Related Content:
